Lim SH, Lee KW, Kim JJ, Im HS, et al. Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06). BMC Cancer 2024;24:252.
PMID: 38395832